Recombinant Human Galanin Peptides (GAL) Protein (His&Myc)

Beta LifeScience SKU/CAT #: BLC-06980P
Greater than 90% as determined by SDS-PAGE.
Greater than 90% as determined by SDS-PAGE.

Recombinant Human Galanin Peptides (GAL) Protein (His&Myc)

Beta LifeScience SKU/CAT #: BLC-06980P
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Submit an inquiry today to inquire about all available size options and prices! Connect with us via the live chat in the bottom corner to receive immediate assistance.

Product Overview

Description Recombinant Human Galanin Peptides (GAL) Protein (His&Myc) is produced by our E.coli expression system. This is a protein fragment.
Purity Greater than 90% as determined by SDS-PAGE.
Uniprotkb P22466
Target Symbol GAL
Species Homo sapiens (Human)
Expression System E.coli
Tag N-10His&C-Myc
Target Protein Sequence GPHAVGNHRSFSDKNGLTSKRELRPEDDMKPGSFDRSIPENNIMRTIIEFLSFLHLKEAGALDRLLDLPAAASSEDIERS
Expression Range 44-123aa
Protein Length Partial
Mol. Weight 16.4 kDa
Research Area Cardiovascular
Form Liquid or Lyophilized powder
Buffer Liquid form: default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Reconstitution Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%.
Storage 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C.
Notes Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Target Details

Target Function Endocrine hormone of the central and peripheral nervous systems that binds and activates the G protein-coupled receptors GALR1, GALR2, and GALR3. This small neuropeptide may regulate diverse physiologic functions including contraction of smooth muscle of the gastrointestinal and genitourinary tract, growth hormone and insulin release and adrenal secretion.
Subcellular Location Secreted.
Protein Families Galanin family
Database References

HGNC: 4114

OMIM: 137035

KEGG: hsa:51083

STRING: 9606.ENSP00000265643

UniGene: PMID: 28987550

  • Higher serum galanin levels were determined in patients with impaired glucose tolerance. PMID: 28416367
  • Serum galanin (GAL) levels are significantly higher in the obese group compared with lean subjects during an oral glucose tolerance test (OGTT). PMID: 27550417
  • Galanin per se did not affect the dynamic mass redistribution of natural killer (NK) cells, but significantly enhanced the response of NK cells to IL-18 PMID: 27837916
  • majority of intrinsic choroidal neurons were GAL-positive PMID: 27914762
  • ultraviolet irradiation upregulated galanin mRNA and protein expression in keratinocytes in vitro and in human skin in vivo PMID: 27943416
  • GAL and its receptor GALR3 are differentially methylated and expressed in brains of major depressive disorder subjects in a region- and sex-specific manner. PMID: 27940914
  • Study found dramatic reduction in von Willebrand factor extrusion and multimer expression by the neuropeptide galanin in cultured endocardial endothelial cells from heart failure patients. Results suggest that a combination of beta-blockers and galanin therapy may be one therapeutic option for improving endocardial endothelial anticoagulant function. PMID: 28720509
  • The analyses revealed that the presence of the galanin gene minor allele (G) increased susceptibility to multiple sclerosis in men (OR = 2.49, P = 0.008) but not in women. PMID: 27870457
  • Study provides evidence that GAL and GALR1/2 genes were identified as aberrantly methylated in head and neck squamous cell carcinoma. PMID: 27685843
  • Low levels of plasma galanin is associated with obese subjects with hypertension. PMID: 27538957
  • results indicated that obese individuals have higher plasma GAL and GALP concentrations and both peptide concentrations were positively correlative to triglyceride concentrations in obese human PMID: 27474259
  • GAL and its receptors, GALR1 and GALR2, play a role in head and neck squamous cell carcinoma tumorigenesis PMID: 26572146
  • Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease. PMID: 26253934
  • This study demonstrated that Galanin upregulation within the basal forebrain cholinergic system in LBD PMID: 26621352
  • Galanin released by cancer induces neuritogenesis, facilitating perineural invasion. PMID: 25917569
  • Mutations in the human GAL gene cause temporal lobe epilepsy. PMID: 25691535
  • This is the first report of the various galanin receptors in the human eye. PMID: 26122049
  • Galanin can be regarded as an immunomodulatory peptide as it can sensitize polymorphonuclear neutrophils towards pro-inflammatory cytokines in humans and mice. PMID: 25545502
  • found no association of the galanin enhancer genotype with any of the other pathophysiological parameters measured PMID: 25228436
  • Data shows that high expression of GAL is associated with poor prognosis of stage II colorectal cancer patients (CRC) and GAL expression may be related to the aggressive behavior of CRC. PMID: 25504183
  • The plasma galanin levels are higher in patients with gestational diabetes mellitus than in normal pregnancy. PMID: 24503374
  • Data suggest that plasma levels of galanin and interleukin-6 are up-regulated in second trimester in women with gestational diabetes (glucose intolerant/insulin resistant) as compared to normal pregnant women (with normal glucose/insulin tolerance). PMID: 24397394
  • Galanin plays a crucial role in inhibiting insulin secretion from pancreatic beta cells to prevent hyperinsulinemia, which is a characteristic of type 2 diabetes mellitus. [review] PMID: 24106965
  • Variants in genes for galanin (GAL) and its receptors (GALR1, GALR2, GALR3), despite their disparate genomic loci, conferred increased risk of depression and anxiety in people who experienced childhood adversity or recent negative life events. PMID: 24706871
  • The SNPs of rs694066 in the GAL gene showed a positive correlation with the major depressive disorder in the Chinese Han population. PMID: 23741354
  • Galanin has a role in regulating eccrine sweat gland secretion PMID: 23278944
  • These results suggest that the activation of progalanin by plasmin in the extracellular compartment was involved in MMP-9 and MMP-2 activation and in angiogenesis in tumor tissue. PMID: 23261456
  • Moreover, we have identified a novel role for the GalR1/galanin receptor-ligand axis in chemoresistance, providing evidence to support its further evaluation as a potential therapeutic target and biomarker in colorectal cancer . PMID: 22859720
  • localization of the transcripts for galanin and its receptors (GalR1-R3), tryptophan hydroxylase 2, tyrosine hydroxylase, nitric oxide synthase and the three vesicular glutamate transporters (VGLUT 1-3) in the locus coeruleus and the dorsal raphe nucleus PMID: 23341594
  • The results indicate the continuous presence of GAL-ergic innervation in the immediate vicinity of the cancer invasion, which may be attributed to increased contraction of the affected part of intestine. PMID: 22226150
  • Study revealed that plasmin was present in tumor tissue, and that it was responsible for processing progalanin to galanin(1-20) in the extracellular environment. PMID: 21707521
  • This study suggested that the adenylate GAL related to major depressive disorder. PMID: 21042317
  • Circulating galanin levels at birth are not affected by GDM and IUGR, providing no evidence for alternations in hypothalamic galanin expression and secretion in humans, as they were previously documented in experimental models. PMID: 22162474
  • Analysis in neuroblastoma cells demonstrates that GAL5.1 acts as an enhancer of promoter activity after protein kinase C activation. PMID: 21716262
  • Chronic constriction injury results in galanin upregulation in dorsal root ganglion and sciatic nerve, although less in transgenic mice with nuclear factor-kappaB inhibition. PMID: 21352816
  • Cerebrospinal fluid levels of total but not free IgG autoantibodies against galanin are increased in patients with Alzheimer's disease, resulting in increased percentage of galanin autoantibodies present as immune complexes. PMID: 22078238
  • acute alcohol withdrawal was associated with decreased galanin serum levels PMID: 21199668
  • provides substantive evidence that GAL sustains the expression of genes subserving multiple neuroprotective mechanisms in hyperinnervated cholinergic NB neurons compared to nonhyperinnervated neu-ron PMID: 19749437
  • The reported associations in independent samples of Alzheimer Disease and Major Depressive Disorder support an estrogen-dependent function of GAL in pathophysiology of anxiety and depression, affecting response to antidepressant treatment. PMID: 20237460
  • galanin is expressed developmentally in the DRG PMID: 11712539
  • an involvement of GAL in various physiological functions of the gastrointestinal tract PMID: 12471460
  • data suggest a role for endogenous galanin in the adaptive responses to acute orthostatic stress preventing syncope in susceptible individuals PMID: 12647269
  • Galanin is present in human DRGs together with CGRP and substance P, mostly in small neurons. Galanin may mediate processing of sensory information, especially pain, in human DRGs and dorsal horn. PMID: 12654333
  • The involvement of galanin is reviewed in the modulation of such functions as neurotransmitter release, memory, pain, depression, anxiety, obesity, gut motility, neuroendocrine regulation, development and neuroregeneration. PMID: 12769595
  • corticotroph, but not GH adenomas, express high levels of galanin, in addition to ACTH, and in some tumors both polypeptides are synthesised in the same cell population; galanin levels in plasma were not influenced by the tumor galanin content PMID: 14700749
  • human galanin expresses amphipathic properties in the presence of phospholipids which in turn amplifies its vasoactive effects in the intact peripheral microcirculation. PMID: 14706552
  • These galanin-LHRH and LHRH-galanin contacts may be functional synapses, and they may be the morphological substrate of the galanin-controlled gonadal functions in humans. PMID: 15283968
  • Serum galanin concentration in post-menopausal women is related to severity of climacteric syndrome; presence of nervousness in post-menopausal women is related to lower serum galanin level. PMID: 15648541
  • Blood levels correlate with type 2 diabetes and not with obesity or hormonal status in postmenopause. PMID: 15735230
  • FAQs

    Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

    Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

    Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

    Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

    Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

    Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

    To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

    Recently viewed